Literature DB >> 23344699

Emergence of new norovirus strain GII.4 Sydney--United States, 2012.

.   

Abstract

Noroviruses are the leading cause of epidemic gastroenteritis, including foodborne outbreaks, in the United States. Hospitalization and mortality associated with norovirus infection occur most frequently among elderly persons, young children, and immunocompromised patients. Noroviruses belong to the family Caliciviridae and can be grouped into five genogroups (GI through GV), which are further divided into at least 34 genotypes. Human disease primarily is caused by GI and GII noroviruses, with most outbreaks caused by GII.4 strains. During the past decade, new GII.4 strains have emerged every 2-3 years, replacing previously predominant GII.4 strains. Emergence of these new norovirus strains has often, but not always, led to increased outbreak activity. For example, the previously dominant GII.4 New Orleans strain was not associated with increased norovirus outbreak activity in the United States. CDC collects information on norovirus strains associated with outbreaks in the United States through an electronic laboratory surveillance network called CaliciNet. This report documents the recent emergence of a new GII.4 strain, GII.4 Sydney, which caused most (53%) of the norovirus outbreaks reported through CaliciNet during September-December 2012. Continued surveillance will enable further assessment of the public health implications and significance of this new strain.

Entities:  

Mesh:

Year:  2013        PMID: 23344699      PMCID: PMC4604874     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


Noroviruses are the leading cause of epidemic gastroenteritis, including foodborne outbreaks, in the United States (1). Hospitalization and mortality associated with norovirus infection occur most frequently among elderly persons, young children, and immunocompromised patients. Noroviruses belong to the family Caliciviridae and can be grouped into five genogroups (GI through GV), which are further divided into at least 34 genotypes. Human disease primarily is caused by GI and GII noroviruses, with most outbreaks caused by GII.4 strains (1). During the past decade, new GII.4 strains have emerged every 2–3 years, replacing previously predominant GII.4 strains. Emergence of these new norovirus strains has often, but not always, led to increased outbreak activity. For example, the previously dominant GII.4 New Orleans strain was not associated with increased norovirus outbreak activity in the United States (2). CDC collects information on norovirus strains associated with outbreaks in the United States through an electronic laboratory surveillance network called CaliciNet (3). This report documents the recent emergence of a new GII.4 strain, GII.4 Sydney, which caused most (53%) of the norovirus outbreaks reported through CaliciNet during September–December 2012. Continued surveillance will enable further assessment of the public health implications and significance of this new strain. In March 2012, a new GII.4 norovirus strain was identified in Australia. Named GII.4 Sydney, this emergent strain has since caused acute gastroenteritis outbreaks in multiple countries (4). In the United Kingdom, an early onset of the 2012 winter norovirus season was reported in association with emergence of GII.4 Sydney as the dominant strain implicated in outbreaks.* In the United States, GII.4 Sydney has spread rapidly nationwide, causing an increasing number of outbreaks. During September–December 2012, a total of 141 (53%) of the 266 norovirus outbreaks reported to CaliciNet were caused by GII.4 Sydney. The other outbreaks were caused by 10 different GI and GII genotypes, including GII.4 New Orleans. A statistically significant increase in the proportion of outbreaks caused by GII.4 Sydney was noted: four (19%) of 21 outbreaks in September 2012; 22 (46%) of 48 in October 2012; 70 (58%) of 120 in November 2012; and 45 (58%) of 77 in December 2012† (chi-square test for trend; p<0.01). Most (72 [51%]) of these GII.4 Sydney outbreaks resulted from direct person-to-person transmission; 29 (20%) were foodborne, one (1%) was waterborne, and the transmission mode was unknown in 39 (28%) of the outbreaks. Long-term–care facilities and restaurants were the most frequently reported settings, accounting for 91 (65%) and 18 (13%) of the GII.4 Sydney outbreaks, respectively. During the three previous winters, the peak in reported norovirus outbreaks occurred in January; therefore, at present, it is too early to make an assessment of the relative magnitude of the current season. GII.4 noroviruses remain the predominant cause of norovirus outbreaks, and the GII.4 Sydney strain appears to have replaced the previously predominant strain, GII.4 New Orleans. Compared with other norovirus genotypes, GII.4 noroviruses have been associated with increased rates of hospitalizations and deaths during outbreaks (5). Health-care providers and public health practitioners should remain vigilant to the potential for increased norovirus activity in the ongoing season related to the emergent GII.4 Sydney strain. Continued surveillance for norovirus outbreaks through CaliciNet and additional data on clinical and epidemiologic features of outbreaks collected through the National Outbreak Reporting System (NORS)§ will enable further assessment of the public health implications of the new GII.4 Sydney strain, including any association with increased severity or level of activity in the ongoing 2012–13 winter norovirus season. Proper hand hygiene, environmental disinfection, and isolation of ill persons remain the mainstays of norovirus prevention and control (1).
  5 in total

Review 1.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review.

Authors:  Rishi Desai; Christal D Hembree; Andreas Handel; Jonathan E Matthews; Benjamin W Dickey; Sharla McDonald; Aron J Hall; Umesh D Parashar; Juan S Leon; Benjamin Lopman
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

2.  Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States.

Authors:  Catherine Yen; Mary E Wikswo; Ben A Lopman; Jan Vinje; Umesh D Parashar; Aron J Hall
Journal:  Clin Infect Dis       Date:  2011-08-10       Impact factor: 9.079

3.  Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012.

Authors:  J van Beek; K Ambert-Balay; N Botteldoorn; J S Eden; J Fonager; J Hewitt; N Iritani; A Kroneman; H Vennema; J Vinjé; P A White; M Koopmans
Journal:  Euro Surveill       Date:  2013-01-03

4.  Updated norovirus outbreak management and disease prevention guidelines.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2011-03-04

5.  Novel surveillance network for norovirus gastroenteritis outbreaks, United States.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; Kara Williams; David Lee; Jan Vinjé
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

  5 in total
  42 in total

1.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

3.  Genetic Diversity of Noroviruses Circulating in a Pediatric Cohort in Bangladesh.

Authors:  Martha I Nelson; Mustafa Mahfuz; Preeti Chhabra; Rashidul Haque; Jessica C Seidman; Iqbal Hossain; Monica McGrath; A M Shamsir Ahmed; Stacey Knobler; Jan Vinjé; Tahmeed Ahmed
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

Review 4.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

Authors:  John-Sebastian Eden; Joanne Hewitt; Kun Lee Lim; Maciej F Boni; Juan Merif; Gail Greening; Rodney M Ratcliff; Edward C Holmes; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Virology       Date:  2013-12-25       Impact factor: 3.616

6.  Structural and inhibitor studies of norovirus 3C-like proteases.

Authors:  Daisuke Takahashi; Yunjeong Kim; Scott Lovell; Om Prakash; William C Groutas; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2013-09-17       Impact factor: 3.303

7.  A Waterborne Gastroenteritis Outbreak Caused by Norovirus GII.17 in a Hotel, Hebei, China, December 2014.

Authors:  Meng Qin; Xiao-Gen Dong; Yan-Yan Jing; Xiu-Xia Wei; Zhao-E Wang; Hui-Ru Feng; Hong Yu; Jin-Song Li; Jie Li
Journal:  Food Environ Virol       Date:  2016-04-16       Impact factor: 2.778

8.  Complete nucleotide sequence of a norovirus GII.4 genotype: evidence for the spread of the newly emerged pandemic Sydney 2012 strain to China.

Authors:  Yuqi Huo; Ailing Cai; Hui Yang; Mingli Zhou; Jiaxin Yan; Dingxiang Liu; Shuo Shen
Journal:  Virus Genes       Date:  2013-11-27       Impact factor: 2.332

9.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Norovirus GII.17 Predominates in Selected Surface Water Sources in Kenya.

Authors:  N M Kiulia; J Mans; J M Mwenda; M B Taylor
Journal:  Food Environ Virol       Date:  2014-07-25       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.